GENMAB A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,385.00 DKK | +0.04% |
|
-1.77% | -7.20% |
| 01-31 | Genmab and Pfizer receive positive opinion on Tidvak | FW |
| 01-24 | Goldman Sachs lowers target price for Genmab to DKK 2,066 (2,425), reiterates neutral - BN | FW |
EPS & Dividend: Genmab A/S
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 34.03 | 72.21 | 45.54 | 83.65 | 66.02 | 84.15 | 92.39 | 115.8 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 1,481.50 | 2,463.00 | 2,630.00 | 2,941.00 | 2,155.00 | 1,385.00 | 1,385.00 | 1,385.00 |
| Nbr of stocks (in thousands) | 65,075 | 65,410 | 65,423 | 65,362 | 65,322 | 63,524 | 63,524 | - |
| Announcement Date | 19/02/20 | 23/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | - | - | - |
1DKK in Million2DKK
Estimates
Upcoming events: Genmab A/S
More events
| Yield (N) | Yield (N+1) | P/E ratio (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | 16.45x | 2.59x | 3.35x | ||
| -.--% | -.--% | -302.62x | 7.58x | 10.56x | ||
| 0.37% | 0.4% | 19.01x | 2.39x | 4.42x | ||
| -.--% | -.--% | 475.23x | 8.97x | 17.24x | ||
| -.--% | -.--% | -35.24x | 1.43x | 5.55x | ||
| -.--% | -.--% | -41.46x | 7.26x | 6.09x | ||
| 1.7% | 1.86% | 17.69x | 2.73x | 4x | ||
| - | - | -66.18x | - | - | ||
| -.--% | -.--% | 37.43x | 5.46x | 5.74x | ||
| -.--% | -.--% | -15.04x | 47.51x | 41.72x | ||
| Average | percentage-no-prefix | percentage-no-prefix | 10.53x | 9.55x | 10.96x | |
| Weighted average by Cap. | percentage-no-prefix | percentage-no-prefix | -50.69x | 7.14x | 9.67x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition